ALAPIS Α.Β.Ε.Ε.
Announcement
ALAPIS SA announces that within the framework of realizing its business plan through the partial use of the funds drawn from its recent share capital increase, it proceeded to:
a) the acquisition of the rest 2.73% of Biodomus S.A., at a price of ? 90 th. holding after that a 100% stake in company's share capital and
b) the acquisition of the rest 0.27% of PHARMALEX S.A. at a price of ? 100 th. holding after that a 100% stake in company's share capital.
a) the acquisition of the rest 2.73% of Biodomus S.A., at a price of ? 90 th. holding after that a 100% stake in company's share capital and
b) the acquisition of the rest 0.27% of PHARMALEX S.A. at a price of ? 100 th. holding after that a 100% stake in company's share capital.